Advanced Bio Development
Englewood Cliffs, US · Founded 2013 · Delaware corporation
Find your way into Advanced Bio Development
Sign up to see every warm intro you have to Advanced Bio Development
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Advanced Bio Development team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RF
Ralph FerranteExecutive
JP
Joseph PoliExecutive
JL
Jonathan LondonExecutive
Board
MF
Michael FarelloBoard director
CC
Christopher CasgarBoard director
SD
Scott DahnkeBoard director
Reported raises · per SEC filings
Form D private placements$28.2M disclosed across 5 rounds · 2017–2020
▶$14.1MraisedMay 2021 · 23 investors · OtherRule 506(b)
▶$14.1MraisedMay 2021 · 23 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Scott GreeneExecutive Officer
- Michael TannenbaumDirector
- Michael FarelloDirector
- M. Todd BarteeDirector
- Mark FrenchExecutive Officer, Director
- Kawhi LeonardDirector
- Dennis RobertsonDirector
- Ralph FerranteDirector
- Offering amount
- $16M
- Amount sold
- $14.1M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedDec 2019 · 1 investors · OtherRule 506(b)
▶$1MraisedDec 2019 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michael MillerExecutive Officer
- Mark FrenchDirector
- Michael TannenbaumDirector
- Michael FarelloDirector
- M. Todd BarteeDirector
- Ralph FerranteDirector
- Offering amount
- $5M
- Amount sold
- $1M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedDec 2019 · 2 investors · OtherRule 506(b)
▶$750KraisedDec 2019 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michael TannenbaumDirector
- Michael FarelloDirector
- M. Todd BarteeDirector
- Ralph FerranteDirector
- Sandra KarpmanExecutive Officer
- Offering amount
- $750K
- Amount sold
- $750K
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.1MraisedJul 2018 · 1 investors · OtherRule 506(b)
▶$8.1MraisedJul 2018 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Scott DahnkeDirector
- Ralph FerranteExecutive Officer, Director
- M. Todd BarteeDirector
- Michael FarelloDirector
- Offering amount
- $11.6M
- Amount sold
- $8.1M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$4.3MraisedFeb 2017 · 1 investors · OtherRule 506(b)
▶$4.3MraisedFeb 2017 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michael FarelloDirector
- Ralph FerranteExecutive Officer, Director
- Christopher CasgarDirector
- Joseph PoliExecutive Officer
- Scott DahnkeDirector
- Jonathan LondonExecutive Officer
- Offering amount
- $5.1M
- Amount sold
- $4.3M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Advanced Bio Development raised?
- Advanced Bio Development has disclosed $28.2M raised across 5 rounds.
- Where is Advanced Bio Development headquartered?
- Advanced Bio Development is headquartered in Englewood Cliffs, US.